World

Judge allows congressional subpoena of ex-prosecutor in Trump probe

Apr 20, 2023

Washington [US], April 20: A U.S. judge said on Wednesday she would allow Congress to subpoena a former prosecutor who once led the Manhattan district attorney's criminal investigation into former U.S. President Donald Trump.
Manhattan District Attorney Alvin Bragg, a Democrat, last week sued Republican Representative Jim Jordan to block a subpoena for testimony from Mark Pomerantz, a former prosecutor who once led the office's multiyear investigation of Trump.
The subpoena came from the House of Representatives Judiciary Committee, which Jordan chairs. Pomerantz's deposition is scheduled for Thursday.
After hearing arguments in federal court in Manhattan on whether to block the subpoena, U.S. District Judge Mary Kay Vyskocil issued a written ruling approving the subpoena but encouraging the parties to reach a compromise as to how the subpoena of Pomerantz would proceed.
"Mr. Pomerantz must appear for the congressional deposition," Vyskocil wrote, adding in a reference to a phrase frequently used by Trump's critics, "No one is above the law."
In a statement, a spokesperson for Jordan said the decision shows "Congress has the ability to conduct oversight."
Bragg's office did not immediately respond to a request for comment.
Source: Fijian Broadcasting Corporation

More news

Metropolis Healthcare unveils Key Findings from Molecular Genomics Study in honour of Lung Cancer Awareness Month

Mumbai (Maharashtra) [India], November 22: Lung cancer remains one of the most prevalent and deadly cancers globally, with approximately 2.2 million new cases diagnosed annually, contributing to 18% of all cancer-related deaths, according to the International Agency for Research on Cancer. In India, it continues to be a leading cause of cancer-related mortality. However, advancements in early detection and new treatment options, particularly genetic profiling, are improving survival rates. These innovations are part of precision oncology, a rapidly growing field that customizes treatments based on a patient's unique genetic makeup, enabling personalized care.

Nov 22, 2024